Literature DB >> 9707598

Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin.

Y van de Wal1, Y M Kooy, P A van Veelen, S A Peña, L M Mearin, O Molberg, K E Lundin, L M Sollid, T Mutis, W E Benckhuijsen, J W Drijfhout, F Koning.   

Abstract

Celiac disease is a common severe intestinal disease resulting from intolerance to dietary wheat gluten and related proteins. The large majority of patients expresses the HLA-DQ2 and/or DQ8 molecules, and gluten-specific HLA-DQ-restricted T cells have been found at the site of the lesion in the gut. The nature of peptides that are recognized by such T cells, however, has been unclear so far. We now report the identification of a gliadin-derived epitope that dominantly is recognized by intestinal gluten-specific HLA-DQ8-restricted T cells. The characterization of such epitopes is a key step toward the development of strategies to interfere in mechanisms involved in the pathogenesis of celiac disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707598      PMCID: PMC21459          DOI: 10.1073/pnas.95.17.10050

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').

Authors:  M N Marsh
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

Review 2.  Celiac sprue.

Authors:  J S Trier
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

3.  In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.

Authors:  G de Ritis; S Auricchio; H W Jones; E J Lew; J E Bernardin; D D Kasarda
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

Review 4.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis.

Authors:  L M Sollid; E Thorsby
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

5.  Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease.

Authors:  J H VAN DE KAMER; H A WEIJERS; W K DICKE
Journal:  Acta Paediatr       Date:  1953-05       Impact factor: 2.299

6.  Cell-mediated immunity to a synthetic gliadin peptide resembling a sequence from adenovirus 12.

Authors:  J A Karagiannis; J D Priddle; D P Jewell
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

7.  In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease.

Authors:  G Mantzaris; D P Jewell
Journal:  Scand J Gastroenterol       Date:  1991-04       Impact factor: 2.423

8.  Wheat peptide challenge in coeliac disease.

Authors:  R Sturgess; P Day; H J Ellis; K E Lundin; H A Gjertsen; M Kontakou; P J Ciclitira
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

9.  Possible role for a human adenovirus in the pathogenesis of celiac disease.

Authors:  M F Kagnoff; R K Austin; J J Hubert; J E Bernardin; D D Kasarda
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  68 in total

1.  Getting to grips with gluten.

Authors:  S N McAdam; L M Sollid
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  B cell epitopes of gliadin.

Authors:  A A Osman; T Günnel; A Dietl; H H Uhlig; M Amin; B Fleckenstein; T Richter; T Mothes
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies.

Authors:  Maria Fiorella Mazzeo; Beatrice De Giulio; Stefania Senger; Mauro Rossi; Antonio Malorni; Rosa Anna Siciliano
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

6.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Authors:  Willemijn Vader; Dariusz Stepniak; Yvonne Kooy; Luisa Mearin; Allan Thompson; Jon J van Rood; Liesbeth Spaenij; Frits Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

7.  A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.

Authors:  E H A Spaenij-Dekking; E M C Kooy-Winkelaar; W F Nieuwenhuizen; J W Drijfhout; F Koning
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

8.  Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.

Authors:  Menno van Lummel; Peter A van Veelen; Arnaud Zaldumbide; Arnoud de Ru; George M C Janssen; Antonis K Moustakas; George K Papadopoulos; Jan W Drijfhout; Bart O Roep; Frits Koning
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

9.  T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease.

Authors:  Jan Petersen; Veronica Montserrat; Jorge R Mujico; Khai Lee Loh; Dennis X Beringer; Menno van Lummel; Allan Thompson; M Luisa Mearin; Joachim Schweizer; Yvonne Kooy-Winkelaar; Jeroen van Bergen; Jan W Drijfhout; Wan-Ting Kan; Nicole L La Gruta; Robert P Anderson; Hugh H Reid; Frits Koning; Jamie Rossjohn
Journal:  Nat Struct Mol Biol       Date:  2014-04-28       Impact factor: 15.369

10.  Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.

Authors:  Alessandra Camarca; Robert P Anderson; Gianfranco Mamone; Olga Fierro; Angelo Facchiano; Susan Costantini; Delia Zanzi; John Sidney; Salvatore Auricchio; Alessandro Sette; Riccardo Troncone; Carmen Gianfrani
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.